5N Plus Inc.

The business

5N Plus is a Montréal-headquartered global producer of specialty semiconductors and performance materials. It refines and engineers high-purity metals and compounds — such as tellurium, cadmium, germanium, gallium and bismuth — into products used in renewable energy, space, security, pharmaceutical, medical imaging and industrial applications. The company reports in US dollars, while its shares trade on the TSX in Canadian dollars.

Its Specialty Semiconductors segment supplies critical materials for thin-film solar modules, space solar cells and radiation detectors used in medical imaging and security scanning. This segment drives most of the growth and has backlog stretching to its maximum of 365 days, with 2026 and 2027 described as sold out. The Performance Materials segment sells bismuth-based and other engineered materials for pharmaceutical, health and industrial uses.

Many of these materials are classed as critical minerals, with supply chains heavily concentrated in China. That gives 5N Plus a strategic role for Western customers and governments; in 2026 it was selected by the US Department of War for a US$7.3M award to build domestic gallium arsenide component production.

The moat

Specialized purification and engineering know-how for ultra-high-purity materials, with long qualification cycles that make customers reluctant to switch suppliers.

A strategic position in critical-mineral supply chains outside China, increasingly valued by Western governments and defence and space customers.

A large, multi-year backlog (US$420M at June 30, 2026, equal to 313 days of annualized revenue) that gives visibility on future sales.

Financial snapshot

Most recent reported period : Q2 2026 (quarter ended June 30, 2026). Figures reflect the review date — confirm current numbers before acting.

Free cash flow yield & sustainable growth

Free cash flow yield : ≈-0.3%TTM free cash flow approx. -C$7.5M / market cap approx. C$2.75B (StockAnalysis statistics, Oct 13, 2026)

Free cash flow has been uneven: about US$1.6M in 2023, -US$27.7M in 2024 and a strong US$47.2M in 2025, before falling to about -US$5.3M over the twelve months to June 30, 2026. The swing reflects higher capital spending on capacity expansion (about US$29M trailing) and working capital tied up in inventory as metal input costs rose.

Revenue growth remains strong — Q2 2026 revenue rose 28% to US$122.4M — but margins came under pressure: adjusted gross margin fell to 30.3% from 34.6%, and management expects near-term margin pressure from higher metal and chemical costs. Whether earnings growth turns back into solid free cash flow depends on finishing the capacity expansions, passing through input costs, and working capital normalizing.

See the full free-cash-flow yield ranking →

Valuation & what to watch

At a market cap of approximately C$2.75B, 5N Plus trades at about 31x trailing earnings and about 28x forward earnings, according to StockAnalysis — a growth-company multiple for a business that has rapidly increased profits. Trailing net income of about US$63M is up from roughly US$15M in 2023, and the company reaffirmed 2026 adjusted EBITDA guidance of US$100M to US$105M.

The balance sheet is not a concern: the company reported net debt of only US$23.7M at June 30, 2026, or 0.21x EBITDA. The weak point in the valuation is cash generation — trailing free cash flow was slightly negative, so the shares are priced on earnings growth and backlog rather than on current free cash flow. The stock has been volatile, trading between C$17.01 and C$49.97 over the past year.

Dividend

5N Plus does not pay a dividend; cash is reinvested in capacity expansion and growth.

Risks & the bear case

• Input-cost volatility: prices of specialty metals and chemicals can squeeze margins, as seen in Q2 2026.
• Customer and end-market concentration, particularly in thin-film solar and space solar, makes results sensitive to a few large customers.
• Capacity expansions temporarily reduced operational efficiency in Q2 2026 and carry execution risk.
• The rich valuation (about 31x trailing earnings) leaves little room for disappointment, and the stock has been highly volatile.
• Trade policy and critical-mineral export controls can disrupt supply of raw materials or change competitive dynamics.

Recent developments

2026-08-03: Reported Q2 2026 revenue of US$122.4M (up 28%), adjusted EBITDA of US$26.6M (up 10%), and backlog of US$420.0M; reaffirmed 2026 adjusted EBITDA guidance of US$100M to US$105M.

Early September 2026: Selected by the US Department of War for a US$7.3M award to build domestic gallium arsenide component production.

Verdict

5N Plus has turned into a genuine growth story, with rising revenue, much higher earnings, a sold-out backlog in its semiconductor business and a strategic place in Western critical-mineral supply chains. The balance sheet is light on debt, but cash flow has lagged earnings because of expansion spending and rising input costs, and the stock trades at a premium multiple with large price swings. It suits growth-oriented investors comfortable with volatility; those focused on free cash flow or income may prefer to see margins and cash conversion recover first.